Viewing StudyNCT00088504



Ignite Creation Date: 2024-05-05 @ 11:35 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00088504
Status: COMPLETED
Last Update Posted: 2007-12-21
First Post: 2004-07-27

Brief Title: Merimepodib MMPD in Triple Combination for the Treatment of Chronic Hepatitis C
Sponsor: Vertex Pharmaceuticals Incorporated
Organization: Vertex Pharmaceuticals Incorporated

Organization Data

Organization: Vertex Pharmaceuticals Incorporated
Class: INDUSTRY
Study ID: VX03-497-205
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Vertex Pharmaceuticals Incorporated
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: Robert Kauffman MD PhD
Old Organization: Vertex Pharmaceuticals Incorporated

Collaborators